Literature DB >> 32714846

The effect of bilateral high frequency repetitive transcranial magnetic stimulation on cognitive functions in schizophrenia.

Mehmet Diyaddin Güleken1, Taner Akbaş2, Selime Çelik Erden2, Veysel Akansel3, Zeliha Cengiz Al4, Ömer Akil Özer2.   

Abstract

•Despite their major effects on positive symptoms, antipsychotics do not have a significant effect on cognition in schizophrenia•Bilateral high frequency rTMS targeting dorsolateral prefrontal cortices has been effective on working memory•Bilateral 20 Hz rTMS improved attention and verbal working memory in schizophrenia patients,•It also improved the competence of switching the perceptional set up under a disruptive effect towards new instructions, in this study.
© 2020 Published by Elsevier Inc.

Entities:  

Year:  2020        PMID: 32714846      PMCID: PMC7371913          DOI: 10.1016/j.scog.2020.100183

Source DB:  PubMed          Journal:  Schizophr Res Cogn        ISSN: 2215-0013


  45 in total

Review 1.  Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.

Authors:  P D Harvey; R S Keefe
Journal:  Am J Psychiatry       Date:  2001-02       Impact factor: 18.112

2.  Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study.

Authors:  K F Berman; J L Ostrem; C Randolph; J Gold; T E Goldberg; R Coppola; R E Carson; P Herscovitch; D R Weinberger
Journal:  Neuropsychologia       Date:  1995-08       Impact factor: 3.139

3.  Use of Neuropsychological tests to predict adult patients' everyday functioning.

Authors:  R K Heaton; M G Pendleton
Journal:  J Consult Clin Psychol       Date:  1981-12

4.  Generalized cognitive deficits in schizophrenia: a study of first-episode patients.

Authors:  S Mohamed; J S Paulsen; D O'Leary; S Arndt; N Andreasen
Journal:  Arch Gen Psychiatry       Date:  1999-08

5.  Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial.

Authors:  Mera S Barr; Faranak Farzan; Tarek K Rajji; Aristotle N Voineskos; Daniel M Blumberger; Tamara Arenovich; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Biol Psychiatry       Date:  2012-10-03       Impact factor: 13.382

6.  Perseveration in behavioral neurology.

Authors:  J Sandson; M L Albert
Journal:  Neurology       Date:  1987-11       Impact factor: 9.910

7.  Left dorso-lateral repetitive transcranial magnetic stimulation affects cortical excitability and functional connectivity, but does not impair cognition in major depression.

Authors:  Polash M Shajahan; Mike F Glabus; J Douglas Steele; Alan B Doris; Kay Anderson; Jenny A Jenkins; Patricia A Gooding; Klaus P Ebmeier
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-06       Impact factor: 5.067

Review 8.  Structural neuroimaging in schizophrenia: from methods to insights to treatments.

Authors:  Martha E Shenton; Thomas J Whitford; Marek Kubicki
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

9.  Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial.

Authors:  Kaiming Zhuo; Yingying Tang; Zhenhua Song; Yingchan Wang; Junjie Wang; Zhenying Qian; Hui Li; Qiong Xiang; Tianyi Chen; Zhilei Yang; Yifeng Xu; Xiaoduo Fan; Jijun Wang; Dengtang Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2019-05-08       Impact factor: 2.570

10.  The psychological results of 438 patients with persisting GERD symptoms by Symptom Checklist 90-Revised (SCL-90-R) questionnaire.

Authors:  Ping Li; Fei Wang; Guo-Zhong Ji; Lin Miao; Sihong You; Xia Chen
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

View more
  1 in total

Review 1.  The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis.

Authors:  Rasmus Lorentzen; Tuan D Nguyen; Alexander McGirr; Fredrik Hieronymus; Søren D Østergaard
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.